BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38326749)

  • 1. How Can We Identify Extraprostatic Extension (EPE) Before Surgery? The Use of a Preoperative Prostate MRI EPE Scoring System to Assess Postprostatectomy Locally Advanced Prostate Cancer.
    Bansal U; Estevez A; Black J; Williamson T; Kaul S; Crociani C; Sun J; Tsai LL; Mechaber-Di Fiori J; Gershman B; Chang P; Wagner AA
    J Endourol; 2024 May; 38(5):499-504. PubMed ID: 38326749
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor contact with prostate capsule on magnetic resonance imaging: A potential biomarker for staging and prognosis.
    Kongnyuy M; Sidana A; George AK; Muthigi A; Iyer A; Ho R; Chelluri R; Mertan F; Frye TP; Su D; Merino MJ; Choyke PL; Wood BJ; Pinto PA; Turkbey B
    Urol Oncol; 2017 Jan; 35(1):30.e1-30.e8. PubMed ID: 27567248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extraprostatic Tumor Extension: Comparison of Preoperative Multiparametric MRI Criteria and Histopathologic Correlation after Radical Prostatectomy.
    Park KJ; Kim MH; Kim JK
    Radiology; 2020 Jul; 296(1):87-95. PubMed ID: 32368959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mEPE-score: a comprehensive grading system for predicting pathologic extraprostatic extension of prostate cancer at multiparametric magnetic resonance imaging.
    Gatti M; Faletti R; Gentile F; Soncin E; Calleris G; Fornari A; Oderda M; Serafini A; Strazzarino GA; Vissio E; Bergamasco L; Cirillo S; Papotti MG; Gontero P; Fonio P
    Eur Radiol; 2022 Jul; 32(7):4942-4953. PubMed ID: 35290508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Grading System for the Assessment of Risk of Extraprostatic Extension of Prostate Cancer at Multiparametric MRI.
    Mehralivand S; Shih JH; Harmon S; Smith C; Bloom J; Czarniecki M; Gold S; Hale G; Rayn K; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
    Radiology; 2019 Mar; 290(3):709-719. PubMed ID: 30667329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for the Prediction of Extraprostatic Disease-A Risk Model for Patient-tailored Risk Stratification When Planning Radical Prostatectomy.
    Nyarangi-Dix J; Wiesenfarth M; Bonekamp D; Hitthaler B; Schütz V; Dieffenbacher S; Mueller-Wolf M; Roth W; Stenzinger A; Duensing S; Roethke M; Teber D; Schlemmer HP; Hohenfellner M; Radtke JP
    Eur Urol Focus; 2020 Nov; 6(6):1205-1212. PubMed ID: 30477971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic value of multiparametric MRI-based models in the assessment of extra-prostatic extension of prostate cancer].
    Liu BC; Wang HY; Dong Z; Zhang Y; Bai X; Ding XH; Zhang XJ; Xu W; Zhao J; Hao YW; Ye HY
    Zhonghua Yi Xue Za Zhi; 2023 May; 103(19):1439-1445. PubMed ID: 37198105
    [No Abstract]   [Full Text] [Related]  

  • 8. An Algorithm to Personalize Nerve Sparing in Men with Unilateral High-Risk Prostate Cancer.
    Martini A; Soeterik TFW; Haverdings H; Rahota RG; Checcucci E; De Cillis S; Hermanns T; Fankhauser CD; Afferi L; Moschini M; Mattei A; Kesch C; Heidegger I; Preisser F; Zattoni F; Marquis A; Marra G; Gontero P; Briganti A; Montorsi F; Porpiglia F; Van Basten JP; Van den Bergh RCN; Van Melick HHE; Ploussard G; Gandaglia G; Valerio M
    J Urol; 2022 Feb; 207(2):350-357. PubMed ID: 34547922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Oncotype DX Genomic Prostate Score and Adverse Tumor Pathology After Radical Prostatectomy.
    Covas Moschovas M; Chew C; Bhat S; Sandri M; Rogers T; Dell'Oglio P; Roof S; Reddy S; Sighinolfi MC; Rocco B; Patel V
    Eur Urol Focus; 2022 Mar; 8(2):418-424. PubMed ID: 33757735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological parameters and stromal desmoplastic status affecting accurate diagnosis of extraprostatic extension of prostate cancer using multi-parametric magnetic resonance imaging.
    Okano K; Miyai K; Mikoshi A; Edo H; Ito K; Tsuda H; Shinmoto H
    Int J Urol; 2024 May; 31(5):475-482. PubMed ID: 38193247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of MRI-Based Staging and Pathologic Staging for Predicting Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy.
    Merriman KM; Harmon SA; Belue MJ; Yilmaz EC; Blake Z; Lay NS; Phelps TE; Merino MJ; Parnes HL; Law YM; Gurram S; Wood BJ; Choyke PL; Pinto PA; Turkbey B
    AJR Am J Roentgenol; 2023 Dec; 221(6):773-787. PubMed ID: 37404084
    [No Abstract]   [Full Text] [Related]  

  • 12. Prediction of extraprostatic extension by MRI tumor contact length: difference between anterior and posterior prostate cancer.
    Matsumoto K; Akita H; Narita K; Hashiguchi A; Takamatsu K; Takeda T; Kosaka T; Mizuno R; Kikuchi E; Oya M; Jinzaki M
    Prostate Cancer Prostatic Dis; 2019 Dec; 22(4):539-545. PubMed ID: 30814680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological and 3 Tesla Volumetric Magnetic Resonance Imaging Predictors of Biochemical Recurrence after Robotic Assisted Radical Prostatectomy: Correlation with Whole Mount Histopathology.
    Tan N; Shen L; Khoshnoodi P; Alcalá HE; Yu W; Hsu W; Reiter RE; Lu DY; Raman SS
    J Urol; 2018 May; 199(5):1218-1223. PubMed ID: 29128577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of MRI for diagnosis of extraprostatic extension in prostate cancer.
    Krishna S; Lim CS; McInnes MDF; Flood TA; Shabana WM; Lim RS; Schieda N
    J Magn Reson Imaging; 2018 Jan; 47(1):176-185. PubMed ID: 28387981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between the extent of extraprostatic extension and survival following radical prostatectomy.
    Jeong BC; Chalfin HJ; Lee SB; Feng Z; Epstein JI; Trock BJ; Partin AW; Humphreys E; Walsh PC; Han M
    Eur Urol; 2015 Feb; 67(2):342-6. PubMed ID: 24968968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing Extraprostatic Extension with Multiparametric MRI of the Prostate: Mehralivand Extraprostatic Extension Grade or Extraprostatic Extension Likert Scale?
    Reisæter LAR; Halvorsen OJ; Beisland C; Honoré A; Gravdal K; Losnegård A; Monssen J; Akslen LA; Biermann M
    Radiol Imaging Cancer; 2020 Jan; 2(1):e190071. PubMed ID: 33778694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative staging using magnetic resonance imaging and risk of positive surgical margins after prostate-cancer surgery.
    Jäderling F; Akre O; Aly M; Björklund J; Olsson M; Adding C; Öberg M; Blomqvist L; Nyberg T; Wiklund P; Carlsson S
    Prostate Cancer Prostatic Dis; 2019 Sep; 22(3):391-398. PubMed ID: 30504811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors and oncological outcomes of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy.
    Kumar A; Samavedi S; Mouraviev V; Bates AS; Coelho RF; Rocco B; Patel VR
    J Robot Surg; 2017 Mar; 11(1):37-45. PubMed ID: 27245233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low PI-RADS assessment category excludes extraprostatic extension (≥pT3a) of prostate cancer: a histology-validated study including 301 operated patients.
    Alessi S; Pricolo P; Summers P; Femia M; Tagliabue E; Renne G; Bianchi R; Musi G; De Cobelli O; Jereczek-Fossa BA; Bellomi M; Petralia G
    Eur Radiol; 2019 Oct; 29(10):5478-5487. PubMed ID: 30887199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of MRI to clinical nomogram for predicting pathological stage before radical prostatectomy.
    Lebacle C; Roudot-Thoraval F; Moktefi A; Bouanane M; De La Taille A; Salomon L
    World J Urol; 2017 Sep; 35(9):1409-1415. PubMed ID: 27995303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.